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Can selective MHC downregulation
explain the specificity and genetic
diversity of NK cell receptors?
Paola Carrillo-Bustamante, Can Kesmir* and Rob J. de Boer
Theoretical Biology and Bioinformatics, Department of Biology, Utrecht University, Utrecht, Netherlands
Natural killer (NK) cells express inhibiting receptors (iNKRs), which specifically bind MHC-I
molecules on the surface of healthy cells. When the expression of MHC-I on the cell
surface decreases, which might occur during certain viral infections and cancer, iNKRs
lose inhibiting signals and the infected cells become target for NK cell activation (missing-
self detection). Although the detection of MHC-I deficient cells can be achieved by
conserved receptor-ligand interactions, several iNKRs are encoded by gene families with
a remarkable genetic diversity, containing many haplotypes varying in gene content and
allelic polymorphism. So far, the biological function of this expansion within the NKR
cluster has remained poorly understood. Here, we investigate whether the evolution
of diverse iNKRs genes can be driven by a specific viral immunoevasive mechanism:
selective MHC downregulation. Several viruses, including EBV, CMV, and HIV, decrease
the expression of MHC-I to escape from T cell responses. This downregulation does not
always affect all MHC loci in the same way, as viruses target particular MHC molecules.
To study the selection pressure of selective MHC downregulation on iNKRs, we have
developed an agent-based model simulating an evolutionary scenario of hosts infected
with herpes-like viruses, which are able to selectively downregulate the expression of
MHC-I molecules on the cell surface. We show that iNKRs evolve specificity and,
depending on the similarity of MHC alleles within each locus and the differences between
the loci, they can specialize to a particular MHC-I locus. The easier it is to classify an MHC
allele to its locus, the lower the required diversity of the NKRs. Thus, the diversification of
the iNKR cluster depends on the locus specific MHC structure.
Keywords: agent-based modeling, NK cells, immunoevasion, evolution, NK cell receptors
Introduction
Natural killer (NK) cells are key players of the innate immune system that eliminate viral infected
and tumor cells. To detect aberrant cells and remain tolerant to healthy tissue, NK cells have
several inhibiting and activating receptors, tightly regulating their cytotoxicity. Crucial for this NK
cell mediated immune recognition is the detection of major histocompatibility complex (MHC)
class I molecules on the surface of target cells. Because several MHC molecules are ligands for
inhibitory NK cell receptors (iNKRs), they signal NK cells to remain silent to self healthy cells.
However, the expression of MHC molecules decreases during some viral infections and cancer,
resulting in reduced inhibiting signals for the NK cell, and hence in NK cell activation [missing-self
detection (1)].
Frontiers in Immunology | www.frontiersin.org June 2015 | Volume 6 | Article 3111
Carrillo-Bustamante et al. Selective MHC-downregulation drives NKR evolution
Some of the NK cell receptors (NKRs) are encoded by a
variety of polymorphic multigene families, including the killer
immunoglobulin-like receptors (KIRs) in higher primates (2, 3),
the CD94/NKG2 receptor family in lemurs (4), and the Ly49
gene family in rodents and equids (5, 6). These polygenic NKR
families encode haplotypes that differ in gene content and allelic
polymorphism, resulting in a large variation on the population
level. Because NKR genes segregate independently from MHC-I
genes, the number of possible receptor-ligand combinations is
immense. In addition to these diverse receptor families, there
are also conserved NKR genes, e.g., the inhibiting CD94/NKG2A
receptors in humans andmice. These inhibiting receptors interact
with the also monomorphic HLA-E in humans and Qa-1b in mice
(7–10), providing a simple system for the recognition of missing-
self. But, if these conserved receptor-ligand interactions are able
to successfully detect missing-self, why have other NKR families
evolved to become so polymorphic, polygenic, and specific?
Because of the evolutionary arms race between infectious
pathogens and the immune system, one plausible explanation
for the diversification of NKRs is the selection pressure on NK
cells imposed by the successful immunoevasins evolved by several
pathogens (11, 12). One of the best studied escape mechanisms is
that of MHC-I mimics encoded by Cytomegalovirus (CMV) in
mice and humans (11, 12). To escape from T cell responses, CMV
downregulates the expression ofMHC-I and additionally encodes
MHC-I decoys to evade missing-self detection by NK cells (12,
13). We have previously addressed the effect of decoy molecules
on the evolution of NKRs with agent-based models (ABM) (14,
15), showing that decoy evolving viruses exert a strong selection
pressure on NKRs, resulting in a diversified repertoire of specific
iNKRs.
Importantly, our previous studies also showed that for sim-
ple detection of MHC downregulation, degenerate iNKRs are
advantageous (14). Therefore, neither specificity nor diversity
evolves in populations infectedwith viruses downregulatingMHC
molecules. In those simulations, we assumed that all MHC
molecules in the host were targeted by the virus. However, a more
common immunoevasive mechanism is that of selective MHC
downregulation, i.e., when the downregulation does not affect
all MHC molecules in the same way, but only particular MHC-
I molecules are targeted by the virus. Several viruses, including
Epstein-Barr-Virus (EBV), CMV, and the human immunodefi-
ciency virus (HIV), decrease the expression of MHC-I of the
cells they infect in a selective manner [reviewed in Ref. (16)].
For example, HCMV encodes several immunoevasin proteins that
selectively downregulate the expression of MHC-I on the cell
surface (16) like US2 and US11, each targeting particular HLA-
A and HLA-B alleles by promoting their export into the cytosol
for proteosomal degradation (17–19). In addition to selective
MHC-downregulation, HCMV encodes proteins that enhance
MHC-I expression to inhibit NK cells, such as UL40 having a
high sequence similarity to protein fragments of HLA-C alleles
(20, 21). HIV-1 also decreases the expression of particular HLA
alleles. HIV Nef binds to the cytoplasmic tails of the HLA-A and
HLA-B molecules in the ER, re-directing them to endolysosomal
compartments for degradation (22). By contrast, HLA-C and -
E have slightly different cytoplasmic tails, so that Nef no longer
hampers their transport to the cell surface. This smart strategy
prevents HIV-infected cells to by lysed by NK cells (23–25).
Since theHLAmolecules presenting peptides to T cells (HLA-A
and -B) tend to be downregulated while those inhibiting NK
cells (HLA-C and -E) remain expressed, selective MHC down-
regulation seems to be a good viral strategy to avoid missing-self
detection. This selective downregulation can in turn shape the
evolution of the NK cell receptors, as specific inhibiting receptors
that exclusively recognize only a subset of MHCmolecules can be
advantageous to detect missing-self.
Our previous studies showed that the expression of MHC-I
mimics by viruses provides a solid explanation for the diversi-
fication of iNKRs. Here, we investigate whether selective MHC
downregulation can exert sufficient selection pressure to drive
the evolution of a polygenic and polymorphic NKR system in
the absence of decoys. We develop an ABM of host populations
infected with herpes-like viruses causing chronic infections. Our
simulations show that NKRs readily evolve specificity for a single
MHC locus. The evolution of these “MHC locus specific” detec-
tors depends on the similarity of the MHCmolecules within each
locus, and the difference betweenMHC loci. Accordingly, there is
selection for polygenicity and polymorphism only in those popu-
lations havingMHC-Imolecules that differ sufficiently within one
locus and between the loci.
Results
Agent Based Model
To study the evolution ofNKRs in a host population, we developed
an ABM similar to our previously described models (14, 15).
Briefly, the host population consists of simplified humans infected
with non-lethal viruses causing chronic infections. The hosts are
diploid, carrying two polymorphic MHC loci and an NKR clus-
ter in different chromosomes. We only model inhibitory NKRs
(iNKRs) in this work, as only iNKRs are involved in missing-self
detection. iNKRs and MHCmolecules are modeled with random
sequences of 0s and 1s (i.e., bit strings) as a simplified representa-
tion of amino acids. Whenever the longest adjacent complemen-
tary match between two strings exceeds a binding threshold L,
the molecules can interact (Figure S1 in SupplementaryMaterial).
We model two different groups of MHC molecules, henceforth
referred to as MHC-X and MHC-Y. The molecules within each
MHC group are somewhat similar to each other, and we vary
the hamming distance (HD) of the molecules within one group
between 2, 4, 6, and 8 (see Materials and Methods).
Initially, all hosts carry the same randomly generated NKR
cluster, which is composed of one gene (i.e., we initialize the
populations with homozygous individuals). This iNKR is degen-
erate, i.e., it can recognize everyMHCmolecule in the population.
Upon birth, individuals inherit one NKR haplotype from each
parent. During this process, NKRs can mutate their sequence and
their binding threshold L (Figure S1 in Supplementary Material),
allowing for the emergence of novel receptors (see Materials and
Methods). If a newly generated receptor is so specific that it fails to
recognize any MHC molecule in the population, it will be called
a pseudogene. The maximal number of NKRs that we allow per
host is five genes per haplotype in these simulations. We focus on
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the evolution of NKRs, and therefore fix the polymorphism of the
MHC-X and -Y molecules throughout the simulations.
During development, NK cells undergo an education process
during which their reactivity is “tuned.” The general consensus
is that the binding of iNKRs with their cognate MHC molecules
renders these NK cells functional capacity (26–28). We imple-
ment this process at birth by evaluating the binding of iNKRs
with their MHC ligands in the host. For simplicity, we do not
model individual NK cell subsets, but estimate the total repertoire
of “licensed” receptors per host. In each host, the repertoire of
licensed receptors consists of all iNKRs binding at least one of
the host’s MHC molecules. In our model, only licensed NKRs
participate during an immune response, assuming that at least one
NK cell subset will express at least one licensed receptor and will
become activated and expand upon infection.
We model two viral species causing chronic infections (viral
species A and B). Both viral species can escape the cytotoxicity of
T cells by downregulating the expression of the MHC I molecules
on the surface of the infected cells. The downregulation is specific
to each locus, i.e., virus species A downregulates the MHC-X
molecules in the host, while virus B downregulates the host’s
MHC-Y molecules.
Upon transmission, the host will enter a phase of acute
infection, after which it can either recover or become chroni-
cally infected. Individuals clearing an infection become immune
against that particular viral species for a period of 10 years. Hosts
can be co-infected with both viral species.
The probability of clearing the infection depends on the interac-
tions between the iNKRs and the expressed MHC-I molecules in
the host. For a virus to be cleared, the licensed repertoire of iNKRs
must be able to detect MHC downregulation. If a virus down-
regulates the MHC-X molecules, and all licensed iNKRs interact
only with the MHC-Y molecules, the NK cells will continue to be
inhibited, and will not detect the altered MHC expression. But if
at least one licensed iNKR binds none of the expressed MHC-Y
molecules, the NK cells carrying that receptor will lose an inhibit-
ing signal whenMHC-X is downregulated, become activated, and
provide protection (illustrated in Figure 1).
In a typical simulation, both viral species are introduced after
the population has stabilized (t1= 10000 years). Very rapidly, the
viruses spread through the population, infecting almost every
individual, and causing a drastic reduction of the population size
(Figure 2A, black line). After approximately 2000 host genera-
tions, individuals that can become immune to each or both viral
strains evolve (Figure 2A, cyan, blue, and green lines), causing a
rapid recovery of the total population size. These results suggest
that the initially susceptible host population evolves an NKR
system, providing immunity to both types of infections.
Specific iNKRs Protect Hosts from
(Viral) Infections
To study how the evolution of iNKRs allows the host population
to recover, we next analyze the iNKRs before and after a long
evolutionary period (Figure 2B). The initial haplotype composed
of one degenerate iNKR recognizes all MHC-I in the population,
covering the entire space of both MHC-X and -Y molecules.
After the introduction of the viruses, there is selection for more
MHC-X
licensed
iNKR
Healthy cell
NK cell
MHC-Y
Virus infected
cell
no protection
pcl = 0
protection
pcl = 0.6
FIGURE 1 |Model cartoon of the protection after infection with an
MHC-downregulating virus. An iNKR becomes licensed if it binds at least
one MHC molecule in the host. In this example, the iNKR is licensed by
binding the MHC-X molecule in that host. The virus downregulates the
expression of all MHC-X molecules. The infection can be cleared with a
probability pcl= 0.6 if and only if the licensed iNKR fails to bind all MHC-Y
molecules in that host (see Materials and Methods).
specific iNKRs, as shownby the increase of their binding threshold
L (Figure 2B). As more specific iNKRs evolve, the number of
immune individuals increases, indicating that the expansion of
these specific iNKRs is required for the hosts to clear the infection.
Because of their higher specificity, i.e., higher L, the evolved
iNKRs are expected to recognize fewer MHC molecules than
the initial degenerate receptor. Interestingly, some iNKRs are
still able to recognize most of the MHC-I molecules within one
locus, despite their higher specificity (Figure 2B). For example,
at tend= 5000000, there is one iNKR recognizing all 15 MHC-X
molecules, while binding none of the MHC-Y molecules. This
specialization to the MHC-I loci allows the host to successfully
detect the locus specific MHC-downregulation.
In our model, two processes are crucial in determining NK cell
mediated protection. First, an iNKR must be licensed to partici-
pate in an immune response. Second, the licensed receptor should
be able to detect missing-self. For an iNKR to become licensed,
it must recognize as many MHC molecules as possible in the
population. For instance, an iNKR binding all MHC-X molecules
in the population will get licensed in every host. However, during
an infection with a virus downregulating MHC-X, the licensed
iNKR will only detect missing-self if it fails to recognize all MHC-
Y molecules. Therefore, an “MHC-X detector” (i.e., an iNKR
recognizing more MHC-X than Ymolecules) is protective against
viruses downregulating MHC-X molecules. Similarly, an MHC-Y
detector is protective against MHC-Y downregulating viruses.
We further study the evolution of MHC-X and MHC-Y detec-
tors by clustering the iNKRs according to their binding to all
MHC-I molecules in the population (Figure 2C). Our analysis
reveals that after a long evolutionary period most iNKRs special-
ize to one MHC locus, having little overlap in the detection of
MHC-X andMHC-Ymolecules. Taken together, our results show
that viruses downregulating MHC molecules selectively drive the
evolution of iNKRs that are specific for different MHC-I loci.
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A
B
C
FIGURE 2 | The evolution of MHC-X and MHC-Y detectors provides
immunity. (A) Representative simulation of a host population infected with
both viral species. After their introduction at t1=10000, the viruses spread
rapidly through the population, infecting most individuals, and causing a
drastic decrease of the total population size (black line). Most hosts are
chronically infected with both viruses simultaneously (red line). After several
host generations, some hosts evolve immunity to viruses downregulating
MHC-X molecules but remain chronically infected with viruses
downregulating MHC-Y (blue line). Shortly afterwards, other individuals
become immune to viruses downregulating MHC-Y molecules while being
chronically infected with viruses downregulating MHC-X (cyan line). Finally,
hosts that are able to clear both viruses evolve (green line), resulting in a
recovery of the population. (B) MHC coverage per iNKR and average binding
threshold (L) at different time points (snapshots taken from the video
provided in the Supplementary Material). Each iNKR is depicted by one
circle, the size of which represents its frequency in the population. The
position of each circle shows how many MHC-X and MHC-Y molecules in
the population each iNKR can recognize. (C) Clusters of iNKRs at different
time points according to the “current” iNKR-MHC-I binding matrix. We
cluster both rows (MHC molecules) and columns (iNKRs), by using the
Manhattan measure of distance and the Ward clustering algorithm. The heat
map colors represent the iNKR-MHC-I binding; red illustrating binding and
yellow no binding. The MHC molecules in this simulation were modeled with
a hamming distance (HD) of two.
Specialization to the MHC-I Groups Depends on
the Similarity of the MHC Molecules
So far, we analyzed results from simulations where MHC
molecules were highly similar (i.e., MHC molecules having
HD= 2). To analyze how our results depend on the similarity
of the MHC molecules within each locus, we perform several
simulations with a HD of 4, 6, and 8. Additionally, we carry out
one set of simulations in which all MHC molecules were random
bit strings.
Regardless of the similarity of the MHCmolecules, the initially
susceptible host populations recover from the infection after a
long evolutionary period (Figure 3A). Similarly, although all host
populations evolve more specific iNKRs irrespective of the HD,
the evolution of specific MHC detectors is more difficult as the
similarity of the MHC molecules within one locus is decreased
(Figures 3B–E). Host populations carrying the most similar
MHC-I molecules (i.e., HD= 2) evolve four distinct types of
iNKRs: a large group of MHC-Y detectors (ellipse I in Figure 3B),
a small group of highly specific receptors (recognizing fewMHC-
X and -Y molecules, ellipse II), a small group of degenerate recep-
tors (ellipse III), and a large group of MHC-X detectors (ellipse
IV). With decreasing MHC similarity (i.e., increasing HD among
MHC molecules), the classification between the groups is less
clear (Figures 3C,D), and when considering randomMHCs there
is hardly any distinction between of X or Y detectors (Figure 3E).
In populations without any locus specific MHC structure, the
majority of iNKRs evolve high specificity, and bind therefore only
a few molecules of each group. Additionally, there is purifying
selection in these populations, as some MHC-X and -Y detectors
evolve, despite the low similarity of their ligands. However, the
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A
B C
D E
FIGURE 3 | Evolution of MHC-X and MHC-Y detectors depends on the
similarity of the MHC molecules. (A) depicts the average population size out
of 10 simulations at the carrying capacity (k), immediately after the infection, i.e.,
t1= 10000 (for HD 2), and at tend, for simulations considering different similarity
in the MHC molecules. As a control, c, we simulate populations infected with
both viruses, where the probability of clearing the infection is maximal (i.e.,
pcl=0.6) does not depend on the iNKR-MHC interactions. After a long
evolutionary period, all populations evolve immunity. (B–E) show the MHC
coverage per iNKR and the average binding threshold (L) at tend out of all 10
simulations. Each host population has a different degree of MHC-I similarity,
with HD= 2 (C), HD= 4 (C), HD= 6 (D), and completely random MHC
molecules (E). Each iNKR is depicted by one circle, the size of which represents
its frequency in the population. The position of each circle shows how many
MHC-X and MHC-Y molecules in the population each iNKR can recognize. The
boxes in (A) represent the interquartile range, and the bold horizontal lines
represent the median taken out of 10 simulations.
evolution of “excellent” X or Y detectors (i.e., iNKRs recognizing
all MHC alleles from X without binding any molecule from the
Y locus, and vice versa) can only occur if the MHC alleles differ
sufficiently between the loci.
These results were consistent for all 10 simulations we per-
formed, showing that iNKRs become specific as a result of
the selection pressure imposed by the virus. However, the
specialization to the MHC loci occurs mainly if the latter have a
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structure that the iNKRs can adapt to (compare Figure 3E with
Figures 3B–D).
In all these simulations, the host populations evolve a similar
binding threshold, L, regardless of the similarity among their
MHC-I molecules (Figure 3). This is a surprising observation
because it indicates that the binding threshold is not the only factor
mediating specificity and specialization of iNKRs to particular
MHC molecules. To analyze the NKR specificity further, we next
determine the complementarity of iNKRs to the MHC-X and
MHC-Y molecules.
To have an expectation for the complementarity between
iNKRs and MHC molecules, we generate a thousand random
iNKRs and measure their longest complementary adjacent match
(Lc) to randomly generated MHC molecules (see Materials and
Methods and the blue lines inFigures 4A–C). This analysis reveals
that a random NKR is expected to bind 30% of random MHC
molecules with a maximal complementary adjacent match of 3
bits, and no more than 5% of random MHC molecules with a
maximal adjacent complementary match of 6 bits. We use this
“expected” distribution as the control case. We next determine
A B
C D
E F
FIGURE 4 | Evolution of NKR binding affinity depends on the
similarity of the MHC molecules. We study the evolution of the binding
affinity by comparing the complementarity of iNKRs to their MHC-I
molecules. (A–D) depict the fraction of MHC molecules that are recognized
with a particular complementary adjacent length Lc. The blue curve
describes the expected frequency distribution determined by measuring
the Lc between 1000 random NKRs and a pool of random MHC
molecules, and repeating this experiment 1000 times. The black and red
curves represent the frequency distribution of the evolved iNKRs to MHC-X
and MHC-Y molecules, respectively, at tend. The frequency distribution was
determined by measuring the Lc of the evolved MHC-X detectors
(A,C) and MHC-Y detectors (B,D) to the MHC-X and MHC-Y molecules in
their own populations, and averaging over 10 simulations. (A–B) show
simulations considering similar MHC molecules (i.e., HD= 2), and
(C–D) show simulations with less similar MHC molecules (i.e., HD= 6). The
sum of squared residuals (SSR) from the observed complementarity
distributions to the expected Lc distribution is summarized for X detectors
(E) and Y detectors (F) for all 10 simulations performed per setting. The
boxes represent the interquartile range and the bold horizontal lines
represent the median taken out of 10 simulations.
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the distributions of the evolved iNKRs in our simulations by
measuring the longest complementary adjacent match between
each evolved X and Y detectors and theMHC-X and -Ymolecules
in the same population. The frequency distributions of Lc between
the evolved iNKRs and theMHC-X and -Ymolecules deviate from
the control: the distribution of X detectors to MHC-X molecules
is shifted to the right (Figure 4A, black curve), indicating that X
detectors evolve a high complementarity to MHC-X molecules.
At the same time, the distribution of X detectors to MHC-Y
molecules is shifted to the left (Figure 4A, red curve), suggest-
ing that X detectors lose complementarity to MHC-Y molecules.
Indeed, at their evolved binding threshold, X detectors recognize
more than twofold more MHC-X molecules and less than half
MHC-Y molecules than expected. Similarly, MHC-Y detectors
evolve high complementarity to MHC-Y molecules (Figure 4B,
red curve), while losing affinity to MHC-Xmolecules (Figure 4B,
black curve).
The deviation from the expected complementarity depends on
the similarity of the MHC molecules. In simulations with less
similarMHCmolecules (e.g., HD= 6, Figures 4C,D), the evolved
receptors still specialize to their MHC molecules, albeit with
lower complementarity. To quantify the difference to the expected
distribution, we calculate the sum square residuals (SSR) in each
simulation (Figures 4E,F). The lower the similarity of the MHC
molecules, the more challenging it is for an iNKR to specialize
to one MHC locus. Therefore, the complementarity distribution
hardly deviates from the expected distribution with an increasing
HD (e.g., HD= 8). The SSR to the control is close to zero in those
simulations considering randomMHCmolecules.
Taken together, our results show that iNKRs evolve specificity
to detect viruses downregulating particular MHC-molecules.
However, the iNKRs specialization to the different MHC loci
depends on the structure of the MHC molecules: if the MHC
molecules within one locus share a motif and the difference
between MHC loci is large, iNKRs become complementary to
one MHC-I locus, while losing capacity to bind molecules from
other loci.
Similarity of the MHC Molecules Shapes the
Evolution of NKR Diversity
We next analyze the genetic diversity of iNKRs that evolves in
our simulations. As a measure of genetic diversity, we use the
Simpson’s reciprocal index (SRI, see Materials and Methods). We
measure the diversity of the differentNKRhaplotypes (Figure 5A)
A B
C
FIGURE 5 | Evolution of NKR diversity depends on the similarity of the
MHC molecules. We estimate the genetic diversity by computing the
Simpson’s Reciprocal Index (SRIFL) of all haplotypes (A) and iNKRs (B) present
in the population at tend. The SRI score is high in populations with a dissimilar
MHC molecules (i.e., an increased HD) and in those populations infected with
viruses evolving MHC-decoys. Additionally, we estimate the expansion of the
iNKR haplotype, by measuring the number of loci per haplotype (C). The
selection pressure for polygenicity is smaller in populations with highly
structured MHC molecules. The boxes represent the interquartile range, and the
bold horizontal lines represent the median taken out of 10 simulations.
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and of the genes (Figure 5B) that evolve after 5 million years of
evolution. Additionally, we address the evolution of polygenicity
by measuring the number of loci per haplotype (Figure 5C). In all
simulations, the initial haplotype encoding one gene evolves into
multigene haplotypes as a result of the selection pressure exerted
by the viruses. Indeed, at least two iNKRs (one binding all X
molecules, and another one binding all Ymolecules) are necessary
for an optimal missing-self detection. In populations with highly
similar MHC molecules per locus (i.e., HD= 2), these optimal
X and Y detectors readily evolve, resulting in little selection for
polymorphism (Figures 5A,B) and polygenicity (Figure 5C).
By contrast, the selection for diversity increases in simulations
when the MHC molecules have vague motifs, making it difficult
to classify them as members of the X or Y locus (e.g., HD= 8
in Figure 5). In these cases, iNKRs evolve a high specificity to
detect the particular MHC-molecules that have been selectively
downregulated.However, if iNKRs are very specific, they also have
a high chance of not recognizing any MHC molecule in the host,
and will therefore not become licensed. The chance of having at
least one licensed iNKR per host (i.e., one iNKR binding to one
of the four MHC-I molecules in that same host) is increased in
individuals carrying several functionally different iNKRs. There-
fore, heterozygote hosts carrying amultigene NKR haplotype (i.e.,
hosts carrying maximal 10 different genes) will have an advantage
over homozygous hosts. Indeed, this heterozygote advantage in
populations with dissimilar MHC molecules (i.e., HD 6) drives
the evolution of a larger genetic diversity (Figures 5A,B) and
polygenicity (Figure 5C).
Selection Pressure Caused by Selective MHC
Downregulation is Similar to that Caused by
MHC-Decoys
To quantify the differences in selection pressure caused by MHC
decoys and selective MHC downregulation, we ran another set of
simulations in which host populations are infected with viruses
downregulating all MHC molecules within a host, and addition-
ally expressing an MHC decoy (see Materials and Methods). To
make a rigorous comparison, we use the same configuration as in
the simulations considering selective MHC downregulation, i.e.,
we assume that if at least one of the licensed iNKR detects missing
self (and is not “fooled” by the decoy), the host will be able to clear
the infection (see Materials and Methods).
In a host population carrying random MHC molecules, the
selection pressure exerted by decoys is similar to that exerted
by selective MHC downregulation in populations with somewhat
dissimilar MHC molecules (Figure 5). To distinguish self MHC
molecules from decoys, more specific iNKRs evolve, recognizing
approximately 20% of MHC molecules in the population (results
not shown). Because of the higher specificity, it is more chal-
lenging for the iNKRs within a host to become licensed. Also
here, the pressure to increase the licensed repertoire results in the
selection for polygenicity (Figure 5C) and some polymorphism
(Figures 5A,B).
Discussion
The functional relevance of the remarkable genetic diversity
of NKRs remains intriguing. In this work, we investigate the
evolution of NKRs in host populations that are infected with
viruses that downregulate non-overlapping subsets of MHC-I
molecules.We find that this selectiveMHCdownregulation drives
the evolution of specific iNKRs, which can specialize to the differ-
ent MHC loci if the MHCmolecules in one locus share structural
motifs.
In order to develop an insightful model of a complex evolution-
ary process, simplifying assumptions were necessary. Therefore,
we ignore the synergy between NKRs or the direct interaction
between immune cells, and focus here only on the NK mediated
immune response. Furthermore, we do not model individual NK
cells but consider a global NKR repertoire composed of iNKRs
only. Although the role of activating receptors and their genetic
diversity is equally fascinating, we did not include them in our
simulations, as they are not involved in the recognition ofmissing-
self. We also have chosen to fix the MHC polymorphism in our
simulations, despite the evidence of the co-evolution between
MHC class I and KIRs (29, 30). Given their different evolutionary
timescales, i.e., that MHCmolecules are older than both Ly49 and
KIRs, we chose to model the expansion and contraction of NKR
systems within an already existing MHC diversity. A fixed MHC
polymorphism has also the advantage that it enables us to have a
clean experiment in which we can study rigorously the evolution
of iNKRs. Finally, our aim was to quantify the selection pressure
of selectiveMHCdownregulation, and thereforewe have excluded
from our current model other evasion mechanisms such as decoy
molecules.
Several hypotheses have been proposed to describe the factors
affecting the evolution of NKRs, including reproduction success
(29) and viral evasion strategies (11, 12). Probably, the most
intuitive explanation is that NKRsmust be able to detect decreases
in the expression of MHC molecules on the cell surface. We have
previously shown that neither specificity nor genetic diversity
are required to successfully detect missing-self (14). However,
in those studies, we assumed that MHC downregulation affects
all loci. In reality, not all MHC molecules are targeted equally
and the challenge of NK cells might be to detect missing-self,
particularly when only subsets of theMHC-Imolecules are down-
regulated. We show that if MHC molecules within the same
locus are sufficiently similar, iNKRs can easily evolve the ability
to recognize them. These findings are in line with the observa-
tion that inhibiting KIRs (iKIRs) are specialized to four struc-
tural motifs on HLA molecules: A3/A11, Bw4, C1, and C2 (31).
These main ligands for iKIRs are mutually exclusive, differing in
unique residues that are involved in the KIR-pMHC interaction
(31). While residues 77–83 define the structure of Bw4 (32–34),
the dimorphism among HLA-C molecules at position 80, i.e.,
either asparagine or lysine, determines the classification of HLA-
C1 and -C2 alleles (35, 36). Single amino acid substitutions in
these key residues can have large effects on the binding to KIRs,
as shown by a vast range of structural and functional studies
(35, 37–39). Thus, the “micro” structures on HLA molecules
clearly define a pattern for KIR recognition, and optimal detec-
tors of these common MHC structural motifs have indeed
evolved.
Our model predicts that there should be specific detectors for
each locus. However, not all iKIR ligands are locus specific. The
Bw4 epitope is also carried by approximately 25% of HLA-A
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alleles (29), hampering the discrimination between HLA-A and
-B. Furthermore, the majority of HLA-A and -B alleles (approxi-
mately two-thirds in each locus) do not carry these iKIR specific
epitopes, indicating that humans have no optimalHLA-AorHLA-
B detectors. In contrast, the C1 and C2 motifs are carried almost
exclusively byHLA-Cmolecules and are present in all humanpop-
ulations (29). The inhibiting receptors, KIR2DL1 andKIR2DL2/3,
interact with either C1 or C2 (40–44), and are highly frequent in
most human populations, indicating that HLA-C detectors have
indeed evolved. Why only HLA-C specific detectors have evolved
remains puzzling, suggesting that additional evasion mechanisms
were involved in the evolution of HLA-A and B specific KIRs.
A possible explanation is that viruses have evolved to downreg-
ulate only a few subsets of A and B alleles, to escape NK cell
responses in some hosts, which in turn might drive the evolution
of iKIRs specialized to only some subsets of MHC molecules.
Investigating which viral protein targets which MHC molecule,
and extending this understanding to different species would shed
further light into the co-evolutionary processes between MHC-
downregulating viruses and their hosts.
According to our model, the specialization to different MHC
loci can exert selection pressure to evolve novel NKRs, thus pro-
viding a plausible explanation for the polygenicity and polymor-
phism of NKRs. However, the degree of genetic diversity that
evolves in this study is somewhat limited. It could be that other
immuno-evasive mechanisms, e.g., MHC-decoys, exert a stronger
selection pressure on the diversification of iNKRs. We have previ-
ously shown that the selection pressure driven by viruses encoding
MHC-like molecules has a much larger effect on the evolution
of NKR diversity than what we report here (14, 15). This differ-
ence depends strongly on how the host’s protection is modeled,
however. The high iNKR specificity that hosts required to clear
decoy-encoding viruses (which in turn exerts a stronger selection
pressure on theNKRs) depends strongly onwhether at least one or
all iNKRs in the licensed repertoire should be protective. Based on
experimental evidence indicating that one interaction between an
inhibiting NKR and a decoy is sufficient for the host to succumb
the infection (45), we previously assumed that all iNKRs must be
protective to clear the infection. However, it is counterintuitive
to have one inhibiting interaction dominating the host’s NK cell
response. Theoretically, if one iNKR is able to detect missing-self
(i.e., to be protective), the NK cell subsets carrying that receptor
should proliferate and provide some degree of protection. There-
fore, we adopted a more natural assumption in our current model
for selective downregulation, i.e., that a host needs at least one
protective iNKR to clear the infection. The actual protectionmight
lie between all and at least one protective iNKRs, but the current
understanding of the contribution of each NK cell subset to host’s
protection during a viral infection remains limited. Tomechanisti-
cally understand the data (45), the elucidation of howmany iNKRs
are required for protection is absolutely necessary. Nevertheless,
we here show that both immunoevasive mechanisms affect the
diversification of iNKRs.
Summarizing, we have shown that selective MHC downreg-
ulation can drive the evolution of specific NKRs. However, the
evolution of optimal MHC-loci detectors does not require an
extensive degree of genetic diversity. Therefore, selective MHC
downregulation is unlikely to be the only explanation underlying
the extensive genetic diversity observed in the NKR families.
This suggests that the evolution of NKRs is subject to several
viral immunoevasive mechanisms and that all of these contribute
in different degrees to the evolution of polymorphic, polygenic,
and specific NKR genes.
Materials and Methods
Agent Based Model
The ABM consists of two types of agents, i.e., hosts and viruses,
and three types of events: birth, death, and infection. During each
time step of 1week, we screen all hosts in a random order and
confront them to one of the events. Hosts age over time and their
ages, infection states, and infection types are updated at the end
of every time step. This cycle is repeated for 1 million years to
simulate long term evolution.
Themodel used here is based on our previously publishedABM
(15). Briefly, we model a host population consisting of simplified
humans infected with non-lethal viruses causing chronic infec-
tions. The hosts are diploid, carrying two polymorphic MHC loci
and an NKR cluster, which are encoded on different chromo-
somes. Here, we only model the evolution of inhibiting NKRs, as
activatingNKRs are not involved inmissing-self detection.We use
bit strings to model iNKRs and MHC molecules as a simplified
representation of amino acids. To each iNKR, a random binding
threshold L between 1 and 16 is assigned. Molecules are only
allowed to interact if the longest adjacent complementary match
Lc between the strings exceeds this binding threshold L (Figure
S1 in Supplementary Material). Thus, the binding threshold (L)
and the complementarity between bit strings (Lc) determine the
specificity of each receptor. In the following sections, we pro-
vide a detailed description of the differences between the current
model and our previously published models (14, 15). All model
parameters are fully described in Table 1.
MHC Molecules
We create two gene pools of 15 MHC molecules, each which
reflects the most common HLA B and C alleles in the European
population (47). We perform simulations differing in the similar-
ity of their MHC molecules. In the structured simulations, MHC
molecules can have a hamming distance (HD) of maximal 2, 4, 6,
or 8 bits to each other. To create theMHCmolecules with HD= 2,
we first create one random bit string and generate all possible (16)
strings that have a HD= 1 to the original sequence. We take all of
these strings and fill the pool of MHC-X molecules. The pool for
the Y molecules is filled similarly, yet with a different randomly
generated bit string (i.e., the expected HD between X and Y alleles
is 8 bits). For the populations with MHCmolecules with HD= 4,
we repeat this procedure: for each of the “first generationmutants”
(i.e., those with HD= 1 to the original, HD= 2 to each other),
we generate again all possible strings that have a HD= 1. This
ensures that the HD between the strings in the second generation
ismaximally 4.We randomly select 15 strings out of these “second-
generation mutants” to fill one MHC pool. Accordingly, we chose
15 strings from the “third-generation mutants,” and from the
“fourth-generation mutants” to fill the MHC pools with HD= 6
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TABLE 1 | Parameters of the agent-based model.
Parameter Value
Time step 1week
Simulation time 5 million years
Host parametersa
Maximal population size Nmax 5000 individuals
MHC diversity 2 loci, each with 15 alleles
Maximal number of NKR loci per haplotype 5
Bit string length 16 bitsb
Host mutation rate µ (i.e., point mutation) 0.00005 per gene per birth event
Probability of generating a random novel
NKR
0.1 per mutation event
Infectionc
Infection state i 1 (acute), 2 (chronic)
Effect of viral load on the death rate VLi 0.1 (for i=1), 0.06 (for i= 2) per year
Probability of viral transmission during
acute phase pac
0.85 per contact
Probability of viral transmission during
chronic phase pch
0.15 per contac
Probability of clearing the infection pcl 0 if missing-self is not detected, or
0.6 if missing self is detected
Immunity time ti 10 years
Acute infection time tinf 4weeks
Initial conditions
Initial population size Ninit 4500 individuals with homozygous
hosts, encoding two copies of the
same NKR in their gene cluster)
aThe death and birth rate parameters are age-dependent and have been chosen accord-
ing to a human population (46). For a full description of the age-dependency of birth and
death rate, see Ref. (14).
bBy using 16-bit strings, a large enough theoretical repertoire of 65,536 sequences is
represented.
cWe choose the parameters used for the infection such that the epidemic can be
maintained. Changing the length of the acute phase or the probabilities of clearance do
not affect our results on the evolution of the NKRs qualitatively (results not shown).
and HD= 8, respectively. For the simulations with randomMHC
molecules, each gene pool is filled with 15 randomly generated bit
strings. We also use random MHC molecules in the simulations
considering MHC-decoys.
NKR Molecules
During the hosts’ sexual reproduction, iNKR mutate with a rate
µ (see Table 1). In every mutation event, NKRs undergo point
mutation and their L can increase or decrease by one, thereby
simulating a gradual and slowmutation process. To decrease com-
putational time, we additionally allow for the random generation
of a novel bit stringwith a probability p= 0.1within eachmutation
event, and assign a random value 1 L 16. Receptors with L
larger than 13 will typically not recognize any MHC molecules in
the population, and are therefore considered to be non-functional.
We refer to these non-functional NKRs as pseudo genes. This
method allows us to model the contraction and expansion of the
NKR gene complex, as haplotypes containing pseudo genes are
effectively shorter than those composed of fully functional NKRs.
Viral Infections: Selective MHC Downregulation
In these simulations, we consider two viral species. Both species
come with a particular viral load, which is implemented as an
increase of the hosts’s death rate, VLi, depending on the infection
state i (seeTable 1). Both species, A andB, downregulate theMHC
expression in the infected host, but species A downregulates the
molecules in the MHC-X locus, whereas species B downregulates
those in the Y locus. Viruses do not evolve in this model. The
infection will be cleared with a probability pcl depending on the
interactions of the licensed iNKRs with the expressed MHC-
I molecules. Importantly, we do not model T cells explicitly,
but these are implicitly taken into account via the probability
of clearing the infection pcl. We basically assume that if a virus
downregulates MHC-X and/or MHC-Y, it will escape the T cell
responses restricted to X or Y, and we model the lack of T cell
responses by lowering pcl to 0. However, if the NK cells in that
host are able to detect missing self, the host will have a higher
protection. If a virus downregulates all MHC-A molecules, and at
least one licensed iNKR binds none of theMHC-Bmolecules (i.e.,
if there is at least one protective iNKR), theNK cell subset carrying
that receptor will perceive a reduced inhibiting signal, resulting
in a successful missing-self detection. In this case, the infection is
cleared with pcl= 0.6 (see Figure 1).
Viral Infections: MHC Decoys
In these simulations, we reconsider our previous study with
several viruses expressing MHC decoys (14, 15). A decoy virus
downregulates the expression of all MHC molecules in that host
and encodes one MHC-like molecule. The evolution of decoy
molecules is modeled by allowing the virus to adopt a randomly
selected MHC molecule from its host. Because we fix the MHC
polymorphism to 15 alleles per locus, the maximal number of
decoy proteins that can arise in the population is 30. Each virus
comes with a viral load, which is implemented by increasing
the host’s death rate, VLi depending on the infection state i (see
Table 1).
To make a fair comparison with the downregulation model,
we adopt the same rule of protection here (and not use the
previous assumptions as in (14, 15)). We consider different levels
of protection against a decoy virus, depending on the success of
the virus to escape the NK cell response. If one of the licensed
iNKR is not “fooled” by thedecoy molecule (i.e., if there is at
least one protective iNKR), the NK cell subsets carrying that
receptor will successfully detect “missing-self ” and the host will
clear the infection with a probability pcl= 0.6. In contrast, if none
of the licensed iNKRs detects missing-self, the decoy virus will be
successful.Wemodel the immune escape by setting the probability
of clearing the infection to 0, letting the host become chronically
infected.
Model Initialization
The model is initialized with a host population of 4500 individ-
uals, with random ages between 10 and 70 years. Hosts carry two
MHC loci, each of them encoding two genes from the MHC-X
gene pool, and two genes from MHC-Y pool, respectively. The
initial host population is homozygous for NKRs, carrying a NKR
haplotype composed of two copies of one degenerate iNKR, i.e.,
an iNKR being able to recognize all MHCs in the population.
Clustering of NKRs
Wecreate a (nm)matrixA to describe the binding of alln iNKRs
andmMHC-I molecules in the population. If the i-th iNKR binds
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the j-th MHC-I molecule, the entry of the matrix Aij will be 1,
otherwise Aij will be 0. We cluster the iNKRs and the MHC-
I molecules according to this binding matrix by clustering both
rows and columns.We use theManhattanmeasure of distance and
the Ward clustering algorithm.
Genetic Diversity
The Simpson’s Index is a measurement of diversity that can be
interpreted as the probability that two randomly chosenmolecules
from two random hosts in the population are identical. The lower
the Simpson’s Index, the higher is the diversity of molecules in the
population. The reciprocal of the Simpson’s Index (SRI) defines
a “weighted diversity” (48), which was calculated as follows:
SRI = 1PN
i=1 fi2
, where fi is the fraction of the molecule i over
all NKRs in the population, and N is the total number of unique
NKRs. The higher the SRI, the higher the diversity of NKR genes
in the population.
Analysis of Recognized MHC Molecules
To determine the expected distribution of the maximal comple-
mentary match Lc, we generate 1000 random NKRs and measure
their longest complementary adjacent match to randomly gener-
ated MHC molecules. The frequency of recognized MHCs with a
particular Lc is averaged over 1000 of these “experiments.”
To analyze how this distribution changes after evolution, we
measure the longest complementary adjacent matches between
iNKRs and the MHC-A, and MHC-B molecules after 1 million
years of evolution. An iNKR is classified as an MHC-X detector
if it binds to more MHC-X molecules than MHC-Y molecules at
its evolved L. Similarly, MHC-Y detectors are those iNKRs that
recognize a larger number of Y molecules than X molecules. The
rare set of iNKRs recognizing the same number of X and Y MHC
molecules are classified as neutral receptors and are excluded
from this analysis. The final distribution is the average out of 10
simulations.
We also analyze the distribution of Lc between the evolved
iNKRs and randomMHC molecules by measuring the Lc of each
iNKR to randomMHCmolecules, and repeating this experiment
1000 times. This frequency distribution does not deviate from the
expected values (results not shown).
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